Flovent Powder, Metered
Product Images NDC 50090-1245

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-1245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Flovent Diskus Spl Graphic 01)

Chemical Structure (Flovent Diskus Spl Graphic 01)
FDA Label Image

Figure 1. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Bronchodilators Alone (Flovent Diskus Spl Graphic 02)

Figure 1. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Bronchodilators Alone (Flovent Diskus Spl Graphic 02)
FDA Label Image

Figure 2. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids (Flovent Diskus Spl Graphic 03)

Figure 2. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids (Flovent Diskus Spl Graphic 03)
This text appears to be a comparison between two treatments: FLOVENT DISKUS 100 mcg taken twice daily and a placebo. Baseline FEV (Forced Expiratory Volume) measurements are provided for both treatments. Additionally, there is a table or graph showing the percentage change in FEV over time.*
FDA Label Image

Figure 3. A 12-week Clinical Trial Evaluating Flovent Diskus 250 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 04)

Figure 3. A 12-week Clinical Trial Evaluating Flovent Diskus 250 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 04)
FLOVENT DISKUS 250 mcg is a medication that is taken twice daily. It is used to treat respiratory conditions such as asthma. The baseline FEV1 (forced expiratory volume in one second) of the patient is 2.44 L. There is also a placebo group with a baseline FEV1 of 2.46 L. The % change from baseline in FEV1 is being measured over the course of 12 weeks. It appears that there are multiple data points being collected at various time intervals during the study.*
FDA Label Image

Figure 4. A 12-week Clinical Trial Evaluating Flovent Diskus 500 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 05)

Figure 4. A 12-week Clinical Trial Evaluating Flovent Diskus 500 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 05)
FDA Label Image

Figure A (Flovent Diskus Spl Graphic 06)

Figure A (Flovent Diskus Spl Graphic 06)
FDA Label Image

Figure B (Flovent Diskus Spl Graphic 07)

Figure B (Flovent Diskus Spl Graphic 07)
FDA Label Image

Figure C (Flovent Diskus Spl Graphic 08)

Figure C (Flovent Diskus Spl Graphic 08)
FDA Label Image

Figure D (Flovent Diskus Spl Graphic 09)

Figure D (Flovent Diskus Spl Graphic 09)
FDA Label Image

Figure E (Flovent Diskus Spl Graphic 10)

Figure E (Flovent Diskus Spl Graphic 10)
FDA Label Image

Figure F (Flovent Diskus Spl Graphic 11)

Figure F (Flovent Diskus Spl Graphic 11)
FDA Label Image

Figure G (Flovent Diskus Spl Graphic 12)

Figure G (Flovent Diskus Spl Graphic 12)
FDA Label Image

Figure H (Flovent Diskus Spl Graphic 13)

Figure H (Flovent Diskus Spl Graphic 13)
FDA Label Image

Label Image (Lbl500901245)

Label Image (Lbl500901245)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.